Cvs Severe Congestion And Pain Relief Solution
NDC Package 69842-717-06
Package Information
Cvs Severe Congestion And Pain Relief (acetaminophen, guaifenesin, and phenylephrine hydrochloride) solution is ▪do not take more than directed (see Overdose warning)▪do not take more than 6 doses in any 24-hour period▪measure only with dosing cup provided▪do not use dosing cup with other products▪dose as follows or as directed by a doctor▪adults and children 12 years of age and older: 20 mL in dosing cup provided every 4 hours▪children under 12 years of age: do not use. This formulation utilizes a solution delivery system. Marketed by Cvs, this product is identified by NDC 69842-717 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1116568 - acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution
- RxCUI: 1116568 - acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1116568 - acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution
- RxCUI: 1116568 - acetaminophen 650 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution
- RxCUI: 1116568 - APAP 32.5 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 69842 - Cvs
- 69842-717 - Cvs Severe Congestion And Pain Relief
- 69842-717-06 - 180 mL in 1 BOTTLE
- 69842-717 - Cvs Severe Congestion And Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69842-717-06 identifies a specific commercial package of 180 ml in 1 bottle of Cvs Severe Congestion And Pain Relief, a human over the counter drug labeled by Cvs. This solution is formulated for oral use and contains acetaminophen; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs on March 30, 2020. The current certification is valid through December 31, 2026.
How is this Cvs product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842071706. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.